Orange Book product · Brand (NDA)
ALKINDI SPRINKLE
HYDROCORTISONE
At a glance
Sep 29, 2020
Approved
Brand (NDA)
Application
Not listed
TE code
3
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 29, 2020
5 yr 10 mo ago
Today
Patent 9717740 expires
Listed method-of-use patent (U-3075) expiration.
Nov 19, 2032
in 6 yr 6 mo
Patent 9675559 expires
Listed method-of-use patent (U-3075) expiration.
Jan 10, 2033
in 6 yr 8 mo
Patent 9649280 expires
Listed drug product patent expiration.
May 12, 2034
in 8 yr
Pharmaceutical detail
Active ingredient
HYDROCORTISONE
Strength
2MG
Dosage form
GRANULE
Route
ORAL
TE code
Not listed
Application
NDA 213876
Product number
003
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- —CORT-DOMEBrand (NDA)
NDA 009585 · BAYER PHARMS
- 2018HYDROCORTISONEGeneric (ANDA)
ANDA 203810 · ENCUBE
- 2016ALA-CORTGeneric (ANDA)
ANDA 080706 · CROWN LABS
- 2010HYDROCORTISONEGeneric (ANDA)
ANDA 040879 · RISING
- 2004HYDROCORTISONEGeneric (ANDA)
ANDA 040503 · CHARTWELL MOLECULAR
- 1989HYDROCORTISONEGeneric (ANDA)
ANDA 089273 · TOPIDERM
- 1989HYDROCORTISONEGeneric (ANDA)
ANDA 089754 · ALPHARMA US PHARMS
- 1988NOGENIC HCGeneric (ANDA)
ANDA 087427 · IVAX PHARMS
- 1988HYDROCORTISONEGeneric (ANDA)
ANDA 089682 · ACTAVIS MID ATLANTIC
- 1988HYDROCORTISONEGeneric (ANDA)
ANDA 089706 · NASKA
- 1986HYDROCORTISONEGeneric (ANDA)
ANDA 089414 · FOUGERA PHARMS INC
- 1986HYDROCORTISONEGeneric (ANDA)
ANDA 089413 · PHARMADERM
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9717740 | Nov 19, 2032 | in 6 yr 6 mo | U-3075 |
| 9675559 | Jan 10, 2033 | in 6 yr 8 mo | U-3075 |
| 9649280 | May 12, 2034 | in 8 yr | ProductU-3075 |

